Cobimetinib(Cotellic)

Release date: 2026-01-05 14:33:59     Recommended: 41

This product is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations (in combination with vemurafenib), as well as for the mon